Mumbai, August 28: Leading drugmaker Novartis India Ltd today launched the spray form of Otrivin, a nasal decongestant.
The product has been launched by OTC Business Unit, which is part of the company’s operations in India.
Otrivin will be available as a topical nasal decongestant in a modern, easy-to-use direct acting spray format, OTC Business Unit’s India Head, Vineet Singhal, said in a statement here.
The spray will be available over-the-counter (OTC) at chemist stores and is priced at Rs 44 for a 10 ml unit.
“Otrivin has been the market leader in the nasal decongestant category, and has been trusted by health care professionals for several decades. It is now available in spray form that acts directly by constricting the blood vessels in the nasal tissues, leading to relief from congestion,” the statement said.
The product is positioned to be a part of the cough/ cold and allergies segment, an estimated Rs 1,550-crore market in India. Of this, the nasal decongestion segment is about Rs 110 crore and comprises remedies ranging from balms to tablets, inhalers and drops, it said.
The nasal spray can also be used as a dropper. It acts within two minutes and works for as long as 10 hours, the statement said.
—Agencies